GeminIQ Website Logo

Viewing ALGN free

Subscribe for full history, 50+ metrics, screener, watchlist...

ALIGN TECHNOLOGY INC

ALGN

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
1,0601,0951,0059018731,0441,0427618669371,239952
Accounts Receivable Net Current
1,1251,1021,0991,1161,0629961,0111,020951903904908
Available For Sale Securities Debt Securities Curr…
-----002133354556
Inventory Net
215226228244247254254259280297296313
Prepaid Expense And Other Assets Current
216166174187220199291351350274218237
Assets Of Disposal Group Including Discontinued Op…
402828--0------
Assets Current
2,6552,6172,5342,4482,4022,4922,5972,4122,4792,4472,7022,465
Available For Sale Securities Debt Securities Nonc…
-----000481826
Property Plant And Equipment Net
1,1081,1311,1851,2611,2651,2711,2901,2781,2821,2911,2681,279
Operating Lease Right Of Use Asset
110108115117113113121122119118119126
Goodwill
503492492491458443472454458420404415
Intangible Assets Net Excluding Goodwill
1019499103103103116116121828389
Deferred Income Tax Assets Net
1,4711,5141,5561,5481,5231,5571,5701,5781,5711,5901,5921,606
Other Assets Noncurrent
365278254251239234200198122129132138
Assets
6,3146,2346,2346,2196,1036,2156,3666,1586,1566,0846,3196,145
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
124121126114125109109106117113100110
Accrued Liabilities Current
547537546563546598575555497526614600
Deferred Revenue Current
1,2351,2621,2951,3181,3191,3311,3801,3791,4091,4281,4091,397
Liabilities Current
1,9061,9201,9661,9951,9912,0382,0642,0402,0232,0672,1232,107
Accrued Income Taxes Noncurrent
676811110410096112104121117116113
Operating Lease Liability Noncurrent
8383879086889698959799105
Other Liabilities Noncurrent
108114112117131140150158156173179181
Liabilities
2,1652,1852,2762,3062,3092,3632,4222,4002,3962,4532,5172,506
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital
1,5311,5101,4751,4271,3871,3621,3361,2761,2391,1621,1931,142
Accumulated Other Comprehensive Income Loss Net Of…
7075656118636251821211
Retained Earnings Accumulated Deficit
2,5482,4642,4172,4252,3892,4842,5732,4572,5032,4472,6072,485
Stockholders Equity
4,1494,0493,9573,9133,7943,8523,9443,7583,7603,6303,8023,638
Liabilities And Stockholders Equity
6,3146,2346,2346,2196,1036,2156,3666,1586,1566,0846,3196,145
Allowance For Doubtful Accounts Receivable Current
363428242219191716151313
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
555555555555
Preferred Stock Shares Issued
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
200200200200200200200200200200200200
Common Stock Shares Issued
727172727374757575757777
Shares Outstanding
727172727374757575757777

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.58%2.58%-3.98%---------
20250.01%4.19%13.61%3.70%-7.82%-1.23%7.27%15.42%22.97%-8.90%-0.02%-17.28%
2024-11.20%-15.87%-12.60%9.59%18.44%2.91%9.72%-0.34%9.97%-9.85%-8.35%0.67%
2023----1.41%-17.40%-25.33%11.16%37.70%34.90%5.63%-1.13%-10.22%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.39
1.36
1.29
1.23
1.21
1.22
1.26
1.18
1.23
1.18
1.27
1.17
Quick Ratio
1.17
1.16
1.08
1.01
0.97
1.00
0.99
0.88
0.91
0.91
1.03
0.91
Working Capital
749.58M
696.55M
567.63M
452.58M
411.08M
454.41M
533.77M
372.26M
456.27M
380.01M
578.82M
358.39M
Leverage & Debt
Debt to Equity
0.52
0.54
0.58
0.59
0.61
0.61
0.61
0.64
0.64
0.68
0.66
0.69
Debt Ratio
0.34
0.35
0.37
0.37
0.38
0.38
0.38
0.39
0.39
0.40
0.40
0.41
Efficiency & Turnover
Asset Turnover TTM
0.66
0.65
0.63
0.64
0.65
0.65
0.62
0.64
0.65
0.64
0.62
0.63
Days Sales Outstanding TTM
97.45
94.87
96.69
98.34
92.27
86.67
88.23
89.26
85.51
83.31
84.55
89.87
Receivables Turnover TTM
3.75
3.85
3.78
3.71
3.96
4.21
4.14
4.09
4.27
4.38
4.32
4.06
Per Share Metrics
Diluted EPS TTM
6.00
5.65
5.23
6.03
5.56
5.62
5.91
5.94
6.14
5.81
4.72
4.10
Free Cash Flow Per Share TTM
8.17
6.77
7.83
8.70
8.57
8.32
4.99
5.38
6.54
7.96
8.96
7.99
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
67.57%
67.19%
68.41%
69.79%
69.87%
70.00%
69.98%
69.82%
70.06%
70.08%
69.74%
69.87%
Operating Profit Margin TTM
13.59%
13.53%
13.42%
15.15%
14.69%
15.19%
16.03%
16.21%
16.95%
16.66%
15.35%
15.03%
Net Profit Margin TTM
10.50%
10.17%
9.50%
11.04%
10.29%
10.54%
11.15%
11.34%
11.80%
11.52%
9.53%
8.40%
Growth Metrics
Net Revenue Growth (1Y)
2.89%
0.90%
0.56%
0.56%
1.64%
3.54%
4.03%
5.50%
5.72%
3.42%
-1.48%
-6.33%
Net Income Growth (1Y)
4.96%
-2.61%
-14.31%
-2.11%
-11.40%
-5.32%
21.71%
42.33%
46.72%
23.09%
-28.97%
-49.26%
EPS Growth (1Y)
8.10%
0.52%
-11.51%
1.42%
-9.46%
-3.36%
24.69%
44.86%
50.13%
25.93%
-27.55%
-48.02%
Valuation Metrics
P/E TTM
28.48
27.60
23.95
31.40
28.53
37.05
43.04
40.60
53.33
47.05
64.44
86.16
P/B TTM
2.95
2.80
2.29
3.51
3.08
4.05
4.82
4.83
6.56
5.77
6.15
7.44
P/S TTM
2.99
2.81
2.28
3.47
2.94
3.90
4.80
4.60
6.29
5.42
6.14
7.24
Market Cap
12.24B
11.33B
9.06B
13.74B
11.69B
15.61B
19.01B
18.15B
24.65B
20.94B
23.38B
27.06B
Enterprise Value
11.18B
10.23B
8.06B
12.84B
10.81B
14.57B
17.96B
17.39B
23.78B
20.00B
22.14B
26.11B
Calculated Values
Free Cash Flow TTM
583.65M
490.78M
566.63M
631.54M
630.74M
622.65M
373.02M
404.72M
491.58M
608.06M
686.08M
611.65M
Net Debt
-1.06B
-1.10B
-1.01B
-902.34M
-874.07M
-1.04B
-1.04B
-762.46M
-866.88M
-938.52M
-1.24B
-952.30M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-02-18Sale
Owner: Morici, John
Title: EVP, CHIEF FINANCIAL OFFICER
Shares: 7,969
Price/Share: $189.31
Value: $1,508,611.39
Shares Owned: 8,237
Relationship: Officer
Ownership: Direct
2025-08-01Purchase
Owner: Hogan, Joseph M
Title: PRESIDENT AND CEO
Shares: 7,576
Price/Share: $131.49
Value: $996,168.24
Shares Owned: 184,945
Relationship: Director,Officer
Ownership: Direct
2025-07-31Purchase
Owner: Coletti, Julie Ann
Title: EVP, CHIEF LEGAL & REGULATORY
Shares: 42
Price/Share: $109.66
Value: $4,605.72
Shares Owned: 7,110
Relationship: Officer
Ownership: Direct
2024-08-15Purchase
Owner: Larkin, C Raymond Jr
Title: -
Shares: 6,500
Price/Share: $235.33
Value: $1,529,645.00
Shares Owned: 28,247
Relationship: Director
Ownership: Direct
2024-02-29Sale
Owner: Lacob, Joseph
Title: -
Shares: 15,000
Price/Share: $303.77
Value: $4,556,550.00
Shares Owned: 131,994
Relationship: Director
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
93.69%
Inst. Shares: 66,921,006
Shares Outstanding: 71,425,000
2025-12-31
86.93%
Inst. Shares: 63,061,929
Shares Outstanding: 72,542,000
2025-09-30
89.46%
Inst. Shares: 64,746,292
Shares Outstanding: 72,377,000
2025-06-30
87.22%
Inst. Shares: 63,294,205
Shares Outstanding: 72,565,000
2025-03-31
82.96%
Inst. Shares: 61,030,317
Shares Outstanding: 73,562,000

ALIGN TECHNOLOGY INC (ALGN) — SEC Financial Statements & Analysis

ALIGN TECHNOLOGY INC (ALGN) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. ALIGN TECHNOLOGY INC trades on ALGN: Nasdaq as: ALGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ALIGN TECHNOLOGY INC reported a 2.89% year-over-year revenue growth, a Gross Profit Margin of 67.57% (TTM), a Debt-to-Equity ratio of 0.52x, a Price-to-Sales (P/S) ratio of 2.99x (TTM), a Price-to-Book (P/B) ratio of 2.95 (TTM), at a market cap of $12.24B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
2.89%
Gross Profit Margin TTM
67.57%
Debt To Equity
0.52x
P/S TTM
2.99x
P/B TTM
2.95
Market Cap
$12.24B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ALIGN TECHNOLOGY INC in?

ALIGN TECHNOLOGY INC (ALGN) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is ALGN's market cap?

ALIGN TECHNOLOGY INC (ALGN) has a market capitalization of $12.24B as of 2026-03-31.

What is ALGN's P/E ratio?

ALIGN TECHNOLOGY INC (ALGN)'s trailing twelve month P/E ratio is 28.48x as of 2026-03-31.

What exchange does ALGN trade on?

ALIGN TECHNOLOGY INC (ALGN) trades on the ALGN: Nasdaq.

Where is ALIGN TECHNOLOGY INC incorporated?

ALIGN TECHNOLOGY INC is incorporated in DE.

Research Faster.
Invest Smarter.

ALIGN TECHNOLOGY INC (ALGN) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.